Note 1 - Reporting Entity |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2017 | |||
Statement Line Items [Line Items] | |||
Disclosure of notes and other explanatory information [text block] |
Aptose Biosciences Inc. (“Aptose” or the “Company”) is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. Aptose is a publicly listed company incorporated under the laws of Canada. The Company’s shares are listed on the Nasdaq Capital Markets and the Toronto Stock Exchange. The head office, principal address and records of the Company are located at
5955 Airport Road, Mississauga, Ontario, Canada, L4V 1R9.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The disclosure of notes and other explanatory information as part of a complete set of financial statements. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|